创建一个标准的住院阿片类药物戒断协议
Ariana Abid1,2, Steve Shoptaw1, Michelle Bholat1
1Family Medicine, UCLA ACCESS, Los Angeles, CA, USA.
MedEdPublish (2016)
|July 27, 2023
概括
医院可以通过使用新的布普伦诺芬协议来治疗阿片类药物使用障碍 (OUD) 的住院患者来降低成本. 这种基于证据的方法解决了住院治疗期间的阿片类药物戒断问题,改善了患者的治疗结果.
科学领域:
- 成 药物 药物 药物 药物
- 医院管理局 医院管理局
- 药理学 药理学是指药理学的学科.
背景情况:
- 在美国医院中,阿片类药物使用障碍 (OUD) 治疗的使用率不足.
- 未经治疗的阿片类药物戒断导致高医疗费用和患者离开.
- 布普伦诺芬是OUD的安全有效药物.
研究的目的:
- 开发和实施使用布普伦诺芬的实用阿片类药物戒断协议.
- 解决主要医疗状况的住院患者的阿片类药物戒断问题.
- 为了降低与未经治疗的阿片类药物戒断相关的医疗保健成本.
主要方法:
- 开发了一种与电子医疗记录订单集的协议.
- 使用临床阿片类药物戒断量表进行监测.
- 整合医生,护理,药房和病例管理角色.
主要成果:
- 该协议有助于在住院治疗期间为阿片类药物戒断提供无护理.
- 护理在监测和药物管理中发挥着关键作用.
- 药房和病例管理确保适当的剂量和安全的排出.
结论:
- 挑战包括不一致的成教育和有限的门诊布普伦诺啡因接入.
- 标准化协议可以改善住院OUD患者的护理.
- 需要进一步研究克服实施障碍.
相关概念视频
Opioid Analgesics: Synthetic and Semisynthetic Opioids
338
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
338
Analgesia and Pain Management
660
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
660
Opioid Analgesics: Morphine and Other Natural Cogeners
293
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
293
Opioid Receptors: Overview
1.1K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
1.1K
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents
247
Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
247
Drugs for Treatment of Diarrhea-Predominant IBS
214
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
214


